Dina Masi
2021
In 2021, Dina Masi earned a total compensation of $268.5K as Chief Financial Officer and Senior Vice President at Integrated Biopharma, a 6% increase compared to previous year.
Compensation breakdown
| Option Awards | $16,585 |
|---|---|
| Salary | $242,692 |
| Other | $9,184 |
| Total | $268,461 |
Masi received $242.7K in salary, accounting for 90% of the total pay in 2021.
Masi also received $16.6K in option awards and $9.2K in other compensation.
Rankings
In 2021, Dina Masi's compensation ranked 11,740th out of 12,415 executives tracked by ExecPay. In other words, Masi earned more than 5.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,740 out of 12,415 | 5th |
Division Manufacturing | 5,175 out of 5,505 | 6th |
Major group Chemicals And Allied Products | 2,276 out of 2,375 | 4th |
Industry group Drugs | 2,018 out of 2,096 | 4th |
Industry Pharmaceutical Preparations | 1,492 out of 1,546 | 4th |
Source: SEC filing on October 27, 2021.
Masi's colleagues
We found three more compensation records of executives who worked with Dina Masi at Integrated Biopharma in 2021.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019